ArticleBlood advances2021

Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy.

Andrew Johnsrud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.